Voloridge Investment Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-52,619
Closed -$1.3M – 1113
2025
Q3
$1.3M Sell
52,619
-285,586
-84% -$6.37M ﹤0.01% 1003
2025
Q2
$7.67M Sell
338,205
-37,912
-10% -$898K 0.03% 633
2025
Q1
$11.4M Sell
376,117
-21,617
-5% -$824K 0.04% 525
2024
Q4
$15.8M Buy
+397,734
New +$17.9M 0.06% 424
2023
Q1
– Sell
-86,349
Closed -$7.11M – 1336
2022
Q4
$7.11M Buy
86,349
+28,568
+49% +$2.36M 0.04% 536
2022
Q3
$4.52M Buy
+57,781
New +$4.62M 0.02% 686
2022
Q2
– Sell
-147,048
Closed -$9.64M – 1403
2022
Q1
$9.64M Buy
+147,048
New +$8.54M 0.05% 418
2021
Q1
– Sell
-89,949
Closed -$4.52M – 1350
2020
Q4
$4.52M Buy
+89,949
New +$3.59M 0.04% 484
2020
Q3
– Sell
-12,303
Closed -$309K – 1215
2020
Q2
$309K Buy
+12,303
New +$307K ﹤0.01% 1132
2016
Q2
– Sell
-95,412
Closed -$5.26M – 281
2016
Q1
$5.26M Buy
+95,412
New +$5.45M 0.12% 149
2015
Q3
– Sell
-6,608
Closed -$518K – 263
2015
Q2
$518K Buy
+6,608
New +$476K 0.03% 257

Other funds holding ACHC

Voloridge Investment Management's ACHC Position: Q4 2025 in Review

Voloridge Investment Management sold out of Acadia Healthcare (ACHC) in Q4 2025, closing a stake of 52,619 shares — an estimated $1.3M sold.

Voloridge Investment Management first reported a position in ACHC in Q2 2015 and held it in 11 quarters. The position peaked at $15.8M in Q4 2024. 254 funds tracked by Wall St. Rank hold ACHC as of Q4 2025.

  • Voloridge Investment Management reported no remaining Acadia Healthcare position as of Q4 2025 after selling out during the quarter.
  • Voloridge Investment Management sold 52,619 Acadia Healthcare shares in Q4 2025, an estimated $1.3M.
  • Voloridge Investment Management first reported a position in Acadia Healthcare in Q2 2015 and held it in 11 quarters.
  • Voloridge Investment Management's Acadia Healthcare position peaked at $15.8M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2025.

Based on Voloridge Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.